Volume 5, Supplement 8SupplementOveractive Bladder in Special Patient PopulationsRodney A AppellOveractive bladderPediatricsGeriatricsAnticholinergic agents
Volume 5, Supplement 8SupplementTransdermal Therapy for Overactive Bladder: Present and FutureVictor W NittiOveractive bladderOxybutyninTransdermal drug deliverySkin reactions
Volume 5, Supplement 8SupplementAntimuscarinic Therapy for the Treatment of Mixed IncontinenceScott MacDiarmidAntimuscarinic agentsTolterodineMixed incontinenceSurgical therapy
Volume 5, Supplement 8SupplementTransdermal Systems for Overactive Bladder: Principles and PracticeDavid R StaskinOveractive bladderOxybutyninTransdermal delivery system
Volume 5, Supplement 8SupplementNeurophysiology of Lower Urinary Tract Infection and DysfunctionMichael B ChancellorNaoki YoshimuraOveractive bladderCapsaicinOxybutyninSerotoninMuscarinic receptors
Volume 5, Supplement 5SupplementLandmark Studies Impacting the Medical Management of Benign Prostatic HyperplasiaHerbert LeporBenign prostatic hyperplasiaLower urinary tract symptomsAcute urinary
Volume 5, Supplement 5SupplementThe Medical Therapy of Prostatic Symptoms Study: What Will We Learn?Kevin M SlawinBenign prostatic hyperplasiaBladder outlet obstructionBenign prostatic
Volume 5, Supplement 5SupplementA Primary Care Physician's Perspective on Benign Prostatic HyperplasiaLouis KuritzkyBenign prostatic hyperplasiaBlockersAdrenergic Receptors